Cubist Systematic Strategies LLC reduced its stake in Teladoc Health Inc (NYSE:TDOC) by 31.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,000 shares of the health services provider’s stock after selling 900 shares during the quarter. Cubist Systematic Strategies LLC’s holdings in Teladoc Health were worth $116,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in TDOC. Northern Trust Corp raised its holdings in Teladoc Health by 4.0% in the 1st quarter. Northern Trust Corp now owns 741,350 shares of the health services provider’s stock valued at $29,876,000 after acquiring an additional 28,743 shares during the period. New York State Common Retirement Fund raised its holdings in Teladoc Health by 24.0% in the 1st quarter. New York State Common Retirement Fund now owns 117,970 shares of the health services provider’s stock valued at $4,754,000 after acquiring an additional 22,845 shares during the period. Russell Investments Group Ltd. raised its holdings in Teladoc Health by 245.8% in the 1st quarter. Russell Investments Group Ltd. now owns 98,321 shares of the health services provider’s stock valued at $3,962,000 after acquiring an additional 69,885 shares during the period. Sei Investments Co. raised its holdings in Teladoc Health by 140.9% in the 1st quarter. Sei Investments Co. now owns 5,716 shares of the health services provider’s stock valued at $231,000 after acquiring an additional 3,343 shares during the period. Finally, Principal Financial Group Inc. raised its holdings in Teladoc Health by 3.4% in the 1st quarter. Principal Financial Group Inc. now owns 118,266 shares of the health services provider’s stock valued at $4,767,000 after acquiring an additional 3,839 shares during the period.

In related news, CEO Jason N. Gorevic sold 25,000 shares of Teladoc Health stock in a transaction that occurred on Monday, July 16th. The shares were sold at an average price of $66.11, for a total value of $1,652,750.00. Following the transaction, the chief executive officer now directly owns 586,184 shares of the company’s stock, valued at $38,752,624.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Adam C. Vandervoort sold 5,551 shares of Teladoc Health stock in a transaction that occurred on Monday, October 8th. The shares were sold at an average price of $73.83, for a total transaction of $409,830.33. Following the completion of the transaction, the insider now directly owns 2,934 shares in the company, valued at $216,617.22. The disclosure for this sale can be found here. Insiders sold 269,261 shares of company stock worth $19,013,966 over the last three months. 3.95% of the stock is currently owned by insiders.

Shares of NYSE:TDOC opened at $65.94 on Friday. The company has a market capitalization of $6.01 billion, a P/E ratio of -39.96 and a beta of 0.57. The company has a current ratio of 3.14, a quick ratio of 3.14 and a debt-to-equity ratio of 0.58. Teladoc Health Inc has a 1 year low of $27.30 and a 1 year high of $89.05.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, August 1st. The health services provider reported ($0.37) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.38) by $0.01. The business had revenue of $94.60 million for the quarter, compared to analysts’ expectations of $91.56 million. Teladoc Health had a negative net margin of 37.78% and a negative return on equity of 19.10%. The firm’s quarterly revenue was up 112.1% compared to the same quarter last year. During the same period last year, the firm posted ($0.28) earnings per share. As a group, equities analysts predict that Teladoc Health Inc will post -1.51 EPS for the current fiscal year.

Several brokerages have recently commented on TDOC. KeyCorp raised their target price on shares of Teladoc Health from $90.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, September 28th. TheStreet cut shares of Teladoc Health from a “c” rating to a “d+” rating in a report on Tuesday. Chardan Capital raised their target price on shares of Teladoc Health from $73.00 to $86.00 and gave the stock a “buy” rating in a report on Friday, August 3rd. Robert W. Baird raised their target price on shares of Teladoc Health from $50.00 to $65.00 and gave the stock a “neutral” rating in a report on Wednesday, July 25th. Finally, Canaccord Genuity reaffirmed a “buy” rating and set a $70.00 target price on shares of Teladoc Health in a report on Thursday, August 2nd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $79.79.

Teladoc Health Profile

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Recommended Story: Hedge Funds – Risk or Reward?

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.